loading

Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
21.37%
37.76
48.02 53.27 36.78 32.20
Interest Income/Expense
2.89%
0.427
0.415 0.391 0.372 0.387
Depreciation and Amortization
0.00%
0.20
0.20 0.20 0.20 0.20
Operating Income/Loss
21.37%
-37.76
-48.02 -53.27 -36.78 -32.20
Income/Loss From Continuing Operations Before Tax
21.75%
-35.58
-45.47 -50.99 -34.16 -30.18
Income/Loss From Continuing Operations After Tax
21.75%
-35.58
-45.47 -50.99 -34.16 -30.18
Net Income/Loss
21.75%
-35.58
-45.47 -50.99 -34.16 -30.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,375%
50.12
2.0248 41.15 40.88 40.86
Diluted Average Shares
2,375%
50.12
2.0248 41.15 40.88 40.86
Basic Earnings Per Share
22.83%
-0.71
-0.92 -1.24 -0.84 -0.74
Diluted Earnings Per Share
22.83%
-0.71
-0.92 -1.24 -0.84 -0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):